Expensify: Still Positive After Q2 Earnings Turnaround And Raised Cash Flow Guidance

Expensify (EXFY) was reiterated as Buy as it returned to non-GAAP profitability, with EBITDA margin improving from -3.9% to +19.6% YoY and free cash flow growth strengthening in 2Q26. FY2026 free cash flow guidance was raised 73% to $13M, alongside support for continued buybacks, with the company repurchasing 7% of shares in 2Q26. The move toward AI-native solutions is cited as driving operating leverage.

Analysis

This is more of a cash-conversion story than a pure AI story. In a small-cap SaaS name, a move from negative to high-teens EBITDA margins usually comes from fixed-cost absorption and pricing discipline, not a dramatic step-up in demand, so the next 1-2 quarters matter more than the headline beat. If revenue is only flat to low-single-digit growth, the stock can still work on scarcity value, but the rerating is more fragile than the margin print suggests.

The buyback is the key second-order lever: in a thinly traded microcap, retiring 7% of shares can create a self-reinforcing float squeeze and support per-share metrics even if the business is only stabilizing. That said, it also means the market may be rewarding capital allocation more than product competitiveness. Larger suites like Intuit, BILL, and Ramp can bundle expense management and keep pricing pressure high, so any share gain from the AI-native shift has to overcome much stronger distribution.

Contrarian takeaway: consensus may be over-indexing on the optics of FCF guidance and underweighting how cyclical SMB software demand can be. The main risk is that the margin expansion is more a one-time cost reset than a durable operating model, and buybacks can mask that for a few quarters. The thesis breaks if next guide fails to hold double-digit EBITDA margin or if FCF falls materially short of the new target, because then the market will reclassify this as a low-growth capital-return story rather than a turnaround.

Key Decisions for Investors

• Tactical long EXFY on pullbacks over the next 4-8 weeks, sized small; use stock rather than options given likely wide spreads and the trade is driven by FCF/buyback support, not a near-term volatility catalyst.
• If looking for relative value, consider long EXFY vs. a short basket of higher-multiple SMB software names such as BILL and/or RAMP into the next earnings window; the thesis is that verified cash generation should outperform narrative-driven growth multiple exposure.
• Set a hard alert for FY2026 FCF guide deterioration or EBITDA margin slipping back below the low-teens range; either would falsify the operating leverage thesis and justify exiting.
• Do not chase size after a pop: if the move is mostly buyback-driven, upside likely compresses once the market has marked the float tighter, and liquidity risk becomes the bigger issue.
• Watch next quarter for customer-retention and revenue trajectory rather than more cost cutting; if top-line stabilizes, the rerating can extend 1-3 months, but if it stalls, the stock likely becomes a capital-return story only.